Archives of Pharmacal Research

Papers
(The TQCC of Archives of Pharmacal Research is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment208
Phytochemistry and pharmacological activity of the genus artemisia99
Pathological angiogenesis and inflammation in tissues89
Astragalus polysaccharide: a review of its immunomodulatory effect87
Biomedical features and therapeutic potential of rosmarinic acid84
Mechanisms of resistance to chemotherapy in non-small cell lung cancer77
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications74
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases69
Skin barrier dysfunction and filaggrin69
Pharmacological effects of harmine and its derivatives: a review68
Understanding of sarcopenia: from definition to therapeutic strategies54
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective54
Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review47
Crosstalk between angiogenesis and immune regulation in the tumor microenvironment46
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes43
Ginkwanghols A and B, osteogenic coumaric acid-aliphatic alcohol hybrids from the leaves of Ginkgo biloba41
The role of mucosal barriers in human gut health38
Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression38
mRNA vaccines: the most recent clinical applications of synthetic mRNA37
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm37
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease: clues to early diagnosis and effective treatment36
The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance35
Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis35
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells34
Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway33
Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics32
Latest research progress on anticancer effect of baicalin and its aglycone baicalein31
Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation31
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides31
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis30
New phenalenone derivatives from the Hawaiian volcanic soil-associated fungus Penicillium herquei FT729 and their inhibitory effects on indoleamine 2,3-dioxygenase 1 (IDO1)29
Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals29
Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives28
β-Sitosterol attenuates liver injury in a rat model of chronic alcohol intake28
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry27
LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination27
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide27
Review on pharmacological effects of gastrodin26
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism26
The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance26
Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells25
Comparative evaluation of bioactive phytochemicals in Spinacia oleracea cultivated under greenhouse and open field conditions24
Phytochemistry and pharmacology of natural prenylated flavonoids24
Function and therapeutic development of exosomes for cancer therapy22
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan22
Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells22
Targeting fatty acid metabolism for fibrotic disorders22
NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling22
Recent progress in development and applications of second near‐infrared (NIR-II) nanoprobes21
Recent progresses in marine microbial-derived antiviral natural products21
Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-α-stimulated endothelial cells via the NF-κB/JNK/p38 MAPK signaling pathway20
Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders20
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities20
Mechanistic diversity involved in the desensitization of G protein-coupled receptors20
New tricyclic systems as photosensitizers towards triple negative breast cancer cells19
Alcoholic liver disease: a new insight into the pathogenesis of liver disease19
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes18
Isoindolin-1-ones from the stems of Nicotiana tabacum and their antiviral activities18
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling18
Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis18
Therapeutic effects of histone deacetylase inhibitors on heart disease18
Triterpenoids from Dysoxylum genus and their biological activities18
Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases18
0.032251119613647